Why the study?
Innate immune signaling must be tightly regulated to avoid excessive inflammation or autoimmunity, but the mechanisms controlling this in human cells require further characterization.
Transposon exonization generates a decoy receptor isoform of IFNAR2 that potently inhibits interferon signaling, revealing a primate-specific mechanism of immune regulation.
May inform interferon pathway studies in primates; leaves open human validation and therapeutic relevance.
Innate immune signaling is essential for clearing pathogens and damaged cells and must be tightly regulated to avoid excessive inflammation or autoimmunity. Here, we found that the alternative splicing of exons derived from transposable elements is a key mechanism controlling immune signaling in human cells. By analyzing long-read transcriptome datasets, we identified numerous transposon exonization events predicted to generate functional protein variants of immune genes, including the type I interferon receptor IFNAR2. We demonstrated that the transposon-derived isoform of IFNAR2 is more highly expressed than the canonical isoform in almost all tissues and functions as a decoy receptor that potently inhibits interferon signaling, including in cells infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Our findings uncover a primate-specific axis controlling interferon signaling and show how a transposon exonization event can be co-opted for immune regulation.
No takes yet. Share an insight, caveat, or question.
Pasquesi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: